Contact
- j.hayler@ucl.ac.uk
- Address
-
University College London
Translational Research Office (TRO)
Maple House, 7th Floor, 149 Tottenham Court Road
London
W1T 7JA
![](https://www.ucl.ac.uk/pharmacy/sites/pharmacy/files/styles/small_image/public/JUDY-HAYLER_v2_resized.jpg?itok=7poLo9CW)
Dr Judy Hayler
Selected research
![Human cancer cells Human cancer cells](https://www.ucl.ac.uk/pharmacy/sites/pharmacy/files/styles/non_responsive/public/iStock_human_cancer_resized.jpg?itok=x8sNEDwU)
*Bruce, Ian; Aklaq, Mohammed; Gedeck, Peter; Hatto, Julia; Hayler, Judy F; et al. Development of isoform selective PI3-kinase inhibitors as pharmacological tools for elucidating the PI3K pathway. Bioorganic & Medicinal Chemistry Letters (2012), 22, 5445-5450.
*Spivey, A C.; Shukla, L; Hayler, J F. Conjugate Addition of 2- and 4-Pyridylcuprates: An Expeditious Asymmetric Synthesis of Natural (-)-Evoninic Acid. Organic Letters (2007), 9(5), 891-894.
Budd, E; Hatto, J D I; Hayler, J F; Legrand, D M; Valade, B. Preparation of 5-phenylthiazole derivatives as phosphatidylinositol 3-kinase inhibitors. WO 2007068473. June 21 2007.